Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer
- PMID: 38468553
- DOI: 10.1111/iju.15451
Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer
Abstract
Objectives: To evaluate the utility of magnetic resonance imaging (MRI) and MRI-ultrasound fusion targeted biopsy (TB) for predicting unexpected extracapsular extension (ECE) in clinically localized prostate cancer (CLPC).
Methods: This study enrolled 89 prostate cancer patients with one or more lesions showing a Prostate Imaging-Reporting and Data System (PI-RADS) score ≥3 but without morphological abnormality in the prostatic capsule on pre-biopsy MRI. All patients underwent TB and systematic biopsy followed by radical prostatectomy (RP). Each lesion was examined by 3-core TB, taking cores from each third of the lesion. The preoperative variables predictive of ECE were explored by referring to RP specimens in the lesion-based analysis.
Results: Overall, 186 lesions, including 81 (43.5%), 73 (39.2%), and 32 (17.2%) with PI-RADS 3, 4, and 5, respectively, were analyzed. One hundred and twenty-two lesions (65.6%) were diagnosed as cancer on TB, and ECE was identified in 33 (17.7%) on the RP specimens. The positive TB core number was ≤2 in 129 lesions (69.4%) and three in 57 lesions (30.6%). On the multivariate analysis, PI-RADS ≥4 (p = 0.049, odds ratio [OR] = 2.39) and three positive cores on TB (p = 0.005, OR = 3.07) were independent predictors of ECE. Lesions with PI-RADS ≥4 and a positive TB core number of 3 had a significantly higher rate of ECE than those with PI-RADS 3 and a positive TB core number ≤2 (37.5% vs. 7.8%, p < 0.001).
Conclusions: Positive TB core number in combination with PI-RADS scores is helpful to predict unexpected ECE in CLPC.
Keywords: MRI‐ultrasound fusion targeted prostate biopsy; PI‐RADS scores; extracapsular extension.
© 2024 The Japanese Urological Association.
Similar articles
-
Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.Eur Urol Oncol. 2018 Oct;1(5):418-425. doi: 10.1016/j.euo.2018.09.006. Epub 2018 Oct 5. Eur Urol Oncol. 2018. PMID: 31158081
-
Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.Eur Urol Focus. 2018 Jul;4(4):540-546. doi: 10.1016/j.euf.2017.01.005. Epub 2017 Jan 26. Eur Urol Focus. 2018. PMID: 28753844
-
The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.World J Urol. 2016 Apr;34(4):525-32. doi: 10.1007/s00345-015-1671-8. Epub 2015 Aug 21. World J Urol. 2016. PMID: 26293117
-
Multiparametric MRI in detection and staging of prostate cancer.Dan Med J. 2017 Feb;64(2):B5327. Dan Med J. 2017. PMID: 28157066 Review.
-
MR-guided biopsy and focal therapy: new options for prostate cancer management.Curr Opin Urol. 2018 Mar;28(2):93-101. doi: 10.1097/MOU.0000000000000471. Curr Opin Urol. 2018. PMID: 29232269 Free PMC article. Review.
Cited by
-
Prospective evaluation of PI-RADSv2.1 using multiparametric and biparametric MRI for detecting clinically significant prostate cancer based on MRI/US fusion-guided biopsy.Jpn J Radiol. 2025 Mar;43(3):472-482. doi: 10.1007/s11604-024-01675-4. Epub 2024 Oct 16. Jpn J Radiol. 2025. PMID: 39412644 Free PMC article.
References
REFERENCES
-
- Moris L, Gandaglia G, Vilaseca A, van den Broeck T, Briers E, de Santis M, et al. Evaluation of oncological outcomes and data quality in studies assessing nerve‐sparing versus non–nerve‐sparing radical prostatectomy in nonmetastatic prostate cancer: a systematic review. Eur Urol Focus. 2022;8:690–700.
-
- Preisser F, Gandaglia G, Arad F, Karakiewicz PI, Bandini M, Pompe RS, et al. Association of neurovascular bundle preservation with oncological outcomes in patients with high‐risk prostate cancer. Prostate Cancer Prostatic Dis. 2021;24:193–201.
-
- Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011;59:962–977.
-
- Park BH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, et al. Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. J Urol. 2014;192:82–88.
-
- Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, et al. Combination of diffusion‐weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014;65:186–192.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous